David Larsen
Stock Analyst at BTIG
(2.16)
# 2,783
Out of 4,898 analysts
76
Total ratings
38.33%
Success rate
-1.26%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $17.47 | +43.10% | 3 | Jul 7, 2025 | |
| CYRX Cryoport | Maintains: Buy | $13 → $10 | $7.50 | +33.33% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $61.55 | +29.98% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $23.47 | +19.30% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $52.03 | -32.73% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $97.34 | +33.55% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $21.71 | +42.79% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $160.13 | +62.37% | 2 | Nov 1, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $20.31 | -1.53% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $25.12 | +178.66% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $4.02 | +74.13% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $282.28 | -14.98% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.46 | +379.45% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $11.32 | +23.67% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.33 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $27.57 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $11.36 | +296.13% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.86 | +444.75% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.25 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $20.89 | +67.54% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.27 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $8.08 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $161.69 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $715.57 | -77.64% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.51 | +508.17% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $70.69 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $64.36 | +32.07% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $7.97 | +188.58% | 1 | Nov 2, 2017 |
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $17.47
Upside: +43.10%
Cryoport
Jul 7, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.50
Upside: +33.33%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $61.55
Upside: +29.98%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $23.47
Upside: +19.30%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $52.03
Upside: -32.73%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $97.34
Upside: +33.55%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $21.71
Upside: +42.79%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $160.13
Upside: +62.37%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $20.31
Upside: -1.53%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $25.12
Upside: +178.66%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $4.02
Upside: +74.13%
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $282.28
Upside: -14.98%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.46
Upside: +379.45%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $11.32
Upside: +23.67%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.33
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $27.57
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $11.36
Upside: +296.13%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.86
Upside: +444.75%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $2.25
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $20.89
Upside: +67.54%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $8.27
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $8.08
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $161.69
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $715.57
Upside: -77.64%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.51
Upside: +508.17%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $70.69
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $64.36
Upside: +32.07%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $7.97
Upside: +188.58%